The OhioT1DM dataset is available to researchers interested in improving the health and wellbeing of people with type 1 diabetes. It contains 8 weeks worth of data for each of 12 people with type 1 diabetes. These people were all on insulin pump therapy with continuous glucose monitoring (CGM). They provided blood glucose data, insulin data, self-reported life-event data, and data from physiological fitness bands. The dataset includes: a CGM blood glucose level every 5 minutes; blood glucose levels from periodic self-monitoring of blood glucose (finger sticks); insulin doses, both bolus and basal; self-reported meal times with carbohydrate estimates; self-reported times of exercise, sleep, work, stress, and illness; and physiological data from fitness bands. A paper fully describing the dataset is available: The OhioT1DM Dataset for Blood Glucose Level Prediction: Update 2020.
To protect the data and ensure that it is used only for research purposes, a Data Use Agreement (DUA) is required. The DUA must be signed by a legal signatory for the research institution as well as by the principal investigator. Researchers can click here to Request the Data Use Agreement for the OhioT1DM Dataset. Once a DUA is executed, the dataset will be released, along with the OhioT1DM Viewer, a tool for data visualization.